NCT01182532

Brief Summary

The study is aimed to evaluate the effectiveness and safety of traditional Chinese medicine (TCM) for treatment of hand, foot, and mouth disease (HFMD).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2010

Geographic Reach
1 country

21 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2010

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 16, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 17, 2010

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2011

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
Last Updated

July 23, 2012

Status Verified

July 1, 2012

Enrollment Period

1.4 years

First QC Date

August 16, 2010

Last Update Submit

July 20, 2012

Conditions

Keywords

Mild type of hand, foot and mouth diseaseTraditional Chinese MedicineEffectivenessSafety

Outcome Measures

Primary Outcomes (2)

  • time to onset

    Refering to the length of time to bring down the fever by 0.5 degrees Celsius after the medicine is taken.

    10 days

  • time of body temperature going back to normal

    Refering to the time of the armpit temperature of lower than 37.0 degrees Celsius, lasting for at least 24 hours, after the medicine is taken.

    10 days

Secondary Outcomes (5)

  • time of symptom disappearance

    10 days

  • case severity rate

    10 days

  • time of tetter and oral ulcer disappearance

    10 days

  • direct medical cost

    10 days

  • safety outcome

    10 days

Study Arms (3)

Western therapy

ACTIVE COMPARATOR
Other: Western therapy

TCM treatment

EXPERIMENTAL
Drug: TCM Syndrome Differentiation and Treatment

Western therapy plus TCM treatment

EXPERIMENTAL

The combination of both western therapy and TCM treatment.

Other: Western therapy plus TCM treatment

Interventions

Symptomatic treatment: vitamin B, vitamin C, mouth care and skin care. 1. Adopting physical cooling therapy, including physical cooling paste or warm bathing, when patient's body temperature is lower than 38.5 degree Celsius; 2. Using Ibuprofen suspension when patient's temperature higher than 38.5 degree Celsius;

Western therapy

1. Lung-Spleen Damp-Heat Syndrome Symptoms: Fever, maculopapule and herpes on hand, foot and buttock; herpes on oral mucous membrane; redness in throat, salivation, tiredness, faint red tongue or reddish tongue, greasy fur, speedy pulse, red and purple fingerprint. Formula: Forsythia suspensa (Thunb.) vahl.(Lian Qiao), Lonicera japonica Thunb (Jin Yin Hua), Scutellaria baicalensis Georgi (Huang Qin), etc. Dosage: Adjusting by age and weight of patients. Decoction. 2. Dampness-Heat Retention Syndrome Symptoms: High fever, dirty color of tetter, tiredness, oral ulcer, reddish tongue or deep red tongue, little saliva, yellow and greasy fur, fine and rapid pulse, deep purple fingerprint. Formula: Forsythia suspensa (Thunb.) vahl.(Lian Qiao), Gardenia jasminoides Ellis (rough Zhi Zi), Scutellaria baicalensis Georgi (Huang Qin), etc. Dosage: Adjusting by age and weight of patients. Decoction.

TCM treatment

1. Symptomatic treatment using the same treatment methods in western therapy group; 2. Syndrome differentiation and treatment adopting the same methods in TCM treatment group.

Western therapy plus TCM treatment

Eligibility Criteria

Age1 Year - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Clinical diagnosis of severe hand-foot-mouth disease patients according to Hand-Foot-Mouth Disease Treatment Guidelines 2010 issued by China's Ministry of Health; More than 1/3 patients should be diagnosed by etiological examination.
  • Less than 48 hours of occurrence of fever and/or occurrence of tetter or herpes.
  • Age of 1-14 years.
  • Patients or their guardians agree to participate in this study and signed the informed consent form.

You may not qualify if:

  • Complicated with other serious primary diseases in organ such as congenital heart disease, chronic hepatitis, nephritis and blood diseases, etc.
  • With history of allergies on traditional Chinese medicine.
  • Patients or their guardians suffering from Psychiatric diseases.
  • Attending other clinical studies on HFMD after diagnosed.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (21)

Anhui Provincial Children's Hospital

Hefei, Anhui, China

Location

The First Affiliated Hospital of Anhui College of Traditional Chinese Medicine

Hefei, Anhui, China

Location

Beijing Ditan Hospital

Beijing, Beijing Municipality, China

Location

Beijing You-An Hospital

Beijing, Beijing Municipality, China

Location

Chongqing Hospital of Traditional Chinese Medicine

Chongqing, Chongqing Municipality, China

Location

Fuzhou Infectious Disease Hospital

Fuzhou, Fujian, China

Location

Xiamen Hospital of Traditional Chinese Medicine

Xiamen, Fujian, China

Location

First Hospital of Lanzhou University

Lanzhou, Gausu, China

Location

Shenzhen Third People's Hospital

Shenzhen, Guangzhou, China

Location

The Fifth Hospital of Shijiazhuang, Hebei

Shijiazhuang, Hebei, China

Location

Wuhan Hospital for Infectious Diseases

Wuhan, Hubei, China

Location

Huhehaote Second Hospital

Hohhot, Inner Mongolia, China

Location

Ninth Hospital of Nanchang

Nanchang, Jiangxi, China

Location

Changchun Infectious Diseases Hospital

Changchun, Jilin, China

Location

Ningxia Hui Autonomous Region Forth People's Hospital

Yinchuan, Ningxia Hui Autonomous, China

Location

The Eighth Hospital of Xi'an City

Xi'an, Shaanxi, China

Location

Shanghai Public Health Center

Shanghai, Shanghai Municipality, China

Location

Chengdu Hospital for Infectious Diseases

Chengdu, Sichuan, China

Location

Xinjiang Hongxing Hospital

Urumuqi, Xinjiang, China

Location

First Affiliated Hospital to Kunming Medical College

Kunming, Yunnan, China

Location

The Sixth People's Hospital of Hangzhou

Hangzhou, Zhejiang, China

Location

MeSH Terms

Conditions

Hand, Foot and Mouth DiseaseMouth Diseases

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Coxsackievirus InfectionsEnterovirus InfectionsPicornaviridae InfectionsRNA Virus InfectionsVirus DiseasesInfectionsStomatognathic Diseases

Study Officials

  • Guoliang Zhang

    An'Hui Chinese Medical College Affiliated No.1 Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief

Study Record Dates

First Submitted

August 16, 2010

First Posted

August 17, 2010

Study Start

May 1, 2010

Primary Completion

October 1, 2011

Study Completion

December 1, 2011

Last Updated

July 23, 2012

Record last verified: 2012-07

Locations